iEmoji Feeds @JCO Precision Oncology (JCOPO_ASCO)
1.
JCO Precision Oncology
@JCOPO_ASCO
Check out what’s popular this week in #JCOPO:
Real-world Experience With Neurotrophic Tyrosine Receptor Kinase… twitter.com/i/web/status/1…
Real-world Experience With Neurotrophic Tyrosine Receptor Kinase… twitter.com/i/web/status/1…
2.
JCO Precision Oncology
@JCOPO_ASCO
Apps are open for @ASCO's Editorial Fellowship! This program is designed to introduce fellows to the peer review,… twitter.com/i/web/status/1…
3.
![JCOPO_ASCO]( "JCOPO_ASCO: Twitter")
4.
![JCOPO_ASCO]( "JCOPO_ASCO: Twitter")
5.
![JCOPO_ASCO]( "JCOPO_ASCO: Twitter")
6.
![JCOPO_ASCO]( "JCOPO_ASCO: Twitter")
7.
![JCOPO_ASCO]( "JCOPO_ASCO: Twitter")
JCO Precision Oncology
@JCOPO_ASCO
See what’s popular this week in #JCOPO:
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage… twitter.com/i/web/status/1…
STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage… twitter.com/i/web/status/1…
JCO Precision Oncology
@JCOPO_ASCO
ctDNA to predict risk of recurrence in esophagogastric cancer
@JCOPO_ASCO
doi.org/10.1200/PO.22.…
RWD 295pts… twitter.com/i/web/status/1…
@JCOPO_ASCO
doi.org/10.1200/PO.22.…
RWD 295pts… twitter.com/i/web/status/1…
Retweet of status by @ArndtVogel
JCO Precision Oncology
@JCOPO_ASCO
Check out what’s popular this week in #JCOPO:
Addition of #GermlineTesting to Tumor-Only Sequencing Improves Det… twitter.com/i/web/status/1…
Addition of #GermlineTesting to Tumor-Only Sequencing Improves Det… twitter.com/i/web/status/1…
JCO Precision Oncology
@JCOPO_ASCO
Check out what’s popular this week in #JCOPO:
Universal #Germline #GeneticTesting for Hereditary Cancer Syndrome… twitter.com/i/web/status/1…
Universal #Germline #GeneticTesting for Hereditary Cancer Syndrome… twitter.com/i/web/status/1…
JCO Precision Oncology
@JCOPO_ASCO
️ Coming soon... The JCO Precision Oncology Conversations podcast premieres September 21!
In this podcast, #JCOPO… twitter.com/i/web/status/1…
In this podcast, #JCOPO… twitter.com/i/web/status/1…
8.
![JCOPO_ASCO]( "JCOPO_ASCO: Twitter")
JCO Precision Oncology
@JCOPO_ASCO
On @JCOPO_ASCO - Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carbopla… twitter.com/i/web/status/1…
Retweet of status by @drenriquegrande
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
